Navigation Links
Texas Health Plans Implementing Cost-Sharing From Employers to Employees by Focusing on Increasing Generic Utilization
Date:9/21/2010

NASHVILLE, Tenn., Sept. 21 /PRNewswire/ -- HealthLeaders-InterStudy, a leading provider of managed care market intelligence, reports that the Texas Employee Group Benefits Program, the state's largest employee group, is implementing further cost-sharing for its members, and will continue to steer members towards generic drugs. According to the Texas Health Plan Analysis, more private groups in Texas are going to be shifting costs to their employees.

According to the report, as more private groups try to save money and as members become more aware of safe pharmaceutical alternatives, generic utilization will continue to increase. Plan members will face higher co-pays if choosing a brand name pharmaceutical when generics are available. In addition, the report also finds that as private groups follow the lead of the Texas Employee Group Benefits Program, members will face increased deductibles, out-of-pocket maximums and coinsurance costs for all members.

"Texas' largest employee group has implemented changes that could make waves among many private groups," states Bill Melville, market analyst with HealthLeaders-InterStudy. "With higher co-pays, the Texas Employee Group Benefits Program could be a signal of what's likely to occur in private employer groups. Additional cost-shifting strategies include increased deductibles, out-of-pocket maximums and coinsurance costs."

Other topics highlighted in the recent Texas Health Plan Analysis include:

  • Changes in the rules governing rebates from pharmaceutical companies, which could lead to a carve-in of pharmacy benefits for the state's Medicaid program.
  • The quick movement of providers moving to establish accountable care organizations

  • Why Pharmaceutical Company Managed Markets Teams Need Health Plan AnalysisHealth Plan Analysis identifies key health plan trends, allowing pharmaceutical companies to create comprehensive strategic plans and sales strategies at stat
    '/>"/>

    SOURCE HealthLeaders-InterStudy
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2

    Related medicine technology :

    1. Vical Receives NIH Grant for an Immunotherapeutic Herpes DNA Vaccine; Herpes Experts at University of Washington and University of Texas to Conduct Preclinical Development
    2. Texas Heart(R) Institute at St. Lukes Episcopal Hospital Initiates First Clinical Trial in the World to Treat a Heart Attack Patient with a Special Stem Cell Type
    3. Caliper Life Sciences Optical Imaging Technology Selected to Aid Tuberculosis Research Efforts by the Texas A&M Health Science Center
    4. Texas Cardiac Arrhythmia Institute at St. Davids Medical Center Selected to Conduct Clinical Trial for Device to Treat Atrial Fibrillation
    5. Texas Back Institute Leads Way in New Facet Joint Clinical Trial
    6. WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System
    7. Cancer Therapy & Research Center at The University of Texas Health Science Center and Oncolytics Biotech(R) Inc. Announce Multi-Trial Clinical Research Collaboration
    8. Three Surgeons in East Texas Are Successfully Integrating a Novel Stem Cell Procedure for Spine Surgeries
    9. Texas State Tests Potential New Cancer-Fighting Weapon
    10. St. Davids South Austin Hospital Leading the Central Texas Region in Laser-Assisted Lead-Extraction Procedures
    11. Texas Cardiac Arrhythmia Institute at St. Davids Medical Center First in the United States to Utilize Newly FDA-Cleared CARTO(R) 3 Navigation System
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/23/2015)... and BOSTON , January 23, 2015 ... discovery and development company, is delighted to announce that the ... awarded to Miles Congreve (Vice President of Chemistry), ... Malcolm Weir (Chief Executive Officer and co-founder) for ...
    (Date:1/22/2015)... Colo. , Jan. 22, 2015  BiOptix is pleased ... as Vice President of Chemistry and Biochemistry. Scott joins ... Pharmaceuticals, AstraZeneca Pharmaceuticals, and Amgen throughout the course of ... development. "Scott is a nationally recognized thought ...
    (Date:1/22/2015)... WOODBRIDGE, ON , Jan. 22, 2015 /PRNewswire/ - Pivotal Therapeutics ... company with a focus on Omega-3 therapies for cardiovascular disease ... summary of the Company,s accomplishments in 2014 and its outlook ... Dear Fellow Shareholders, We would like ...
    Breaking Medicine Technology:Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 2Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 4BiOptix Expands Leadership Team with the Appointment of Dr. Scott Klakamp as Vice President of Chemistry and Biochemistry 2Pivotal Therapeutics: Year in Review and CEO Update 2Pivotal Therapeutics: Year in Review and CEO Update 3Pivotal Therapeutics: Year in Review and CEO Update 4Pivotal Therapeutics: Year in Review and CEO Update 5Pivotal Therapeutics: Year in Review and CEO Update 6Pivotal Therapeutics: Year in Review and CEO Update 7
    ... in Carotid Atherosclerosis, LEXINGTON, Mass., Oct. 24 ... its pivotal clinical trial (PROVIDENCE-1),studying the effect of ... peripheral arterial disease (PAD) will be,presented on November ... late breaker,Scientific Session at the American Heart Association,s ...
    ... Today the National Legal and Policy,Center (NLPC) asked ... for,International Development (USAID) to investigate the possibility that ... groups operating,needle exchange programs for drug users in ... activist George,Soros are recipients of these legally questionable ...
    Cached Medicine Technology:ActivBiotics to Present Results of Pivotal Study in the Treatment of Peripheral Arterial Disease at AHA Meeting 2ActivBiotics to Present Results of Pivotal Study in the Treatment of Peripheral Arterial Disease at AHA Meeting 3Ethics Group Asks USAID Inspector General to Investigate Legality of Grants to Soros Groups 2
    (Date:1/22/2015)... Gabe’s Chemo Duck Program is pleased to announce the ... created for kids with cancer. The Chemo Duck App, available on ... with enjoyable games to help children of all ages living with ... to keep kids entertained, educated and at ease while waiting for ...
    (Date:1/22/2015)... Blue Cross and Blue Shield of Minnesota ... it means to “Live Fearless.” , The “Faces ... their stories about how they or someone they know has ... living in the moment. By telling these types of stories ...
    (Date:1/22/2015)... January 22, 2015 Thousand of GranuFlo ... Care recalled its GranuFlo and NaturaLyte dialysis concentrates continue ... in U.S. District Court, District of Massachusetts, Bernstein Liebhard ... the Court has remanded a case filed by the ...
    (Date:1/22/2015)... York, NY (PRWEB) January 22, 2015 ... College of Sports Medicine flagship journal Medicine & ... with L-Citrulline before exercise may help reduce gastrointestinal ... exercise. 1 , Participants in the double-blind, ...
    (Date:1/22/2015)... Payday lending practices in four southern states worsen ... to the states that permit them, according to a ... Race and Wealth. , While they generate hundreds of ... the same time substantially depress economic activity, according to ...
    Breaking Medicine News(10 mins):Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 3Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2
    ... ... be covered by medical insurance will be provided by Khanna institute in Beverly Hills ... (Vocus) April 13, 2010 -- ... for eye and sight problems, hereby announces that it is offering its Beverly Hills patients ...
    ... contaminated water, and their health effects, will be the ... Superfund Research Program during the next five years. The ... that the Superfund Research Program, funded since 1989, will ... 2015 to conduct the research. Four environmental projects ...
    ... A research project of the Neuroscience Center of the ... sustaining memory traces of visual stimuli in the human ... memory is associated with synchronisation of neurons, which facilitates ... basis of interaction between the brain areas, it was ...
    ... ... that 80% of Women Enjoy Reading or Viewing Pornography; 73% Wish They Were Having More Sex. ... San Francisco, CA (PRWEB) April 13, ... had a copy of What Women Really Want in Bed: The Surprising Secrets Women Wish ...
    ... lowered stroke risk, but only if they didn,t smoke, study ... indulge in moderate drinking, you,ve probably heard that it might ... new British study supports that notion, but it also finds ... apply to smokers. , "Any potential beneficial effect of drinking ...
    ... Autism in ... concern with no known cure. The causes of autism are hotly debated, but a new ... ... of children who have received this stem cell treatment for autism , a group of ...
    Cached Medicine News:Health News:Khanna Institute to Provide Intacs Corneal Implants in Beverly Hills 2Health News:Khanna Institute to Provide Intacs Corneal Implants in Beverly Hills 3Health News:University of Arizona Superfund Research Program receives $14 million 2Health News:Human working memory is based on dynamic interaction networks in the brain 2Health News:'What Women Really Want In Bed' Is A Man's Guide To Giving Her The Sex She Wants 2Health News:'What Women Really Want In Bed' Is A Man's Guide To Giving Her The Sex She Wants 3Health News:'What Women Really Want In Bed' Is A Man's Guide To Giving Her The Sex She Wants 4Health News:Smoking May Erase Heart Benefits of Light Drinking 2Health News:Smoking May Erase Heart Benefits of Light Drinking 3Health News:Thanks to a New Stem Cell Therapy, a 9-year Old Autistic Boy Talks to his Father for the First Time 2Health News:Thanks to a New Stem Cell Therapy, a 9-year Old Autistic Boy Talks to his Father for the First Time 3Health News:Thanks to a New Stem Cell Therapy, a 9-year Old Autistic Boy Talks to his Father for the First Time 4
    ... TME 227 T is a ... temporary cardiac pacing and monitoring ... The TME 227 T features ... myocardium, which allows safe and ...
    For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
    For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
    For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
    Medicine Products: